The purpose of this project is to study if intravenous Exenatide is effective at maintaining
normal blood glucose levels and preventing low blood glucose levels during surgery.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
Amylin Pharmaceuticals, LLC. Eli Lilly and Company